EPKEYO

Serial Number 90324839
606

Registration Progress

Application Filed
Nov 17, 2020
Under Examination
Jul 27, 2021
Approved for Publication
Jun 1, 2021
Published for Opposition
Jun 1, 2021
Registered

Trademark Image

EPKEYO

Basic Information

Serial Number
90324839
Filing Date
November 17, 2020
Published for Opposition
June 1, 2021
Abandonment Date
September 2, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 2, 2024
Classes
005 044

Rights Holder

XENON PHARMACEUTICALS INC.

03
Address
200-3650 Gilmore Way
Burnaby, B.C. V5G4W8
CA

Ownership History

XENON PHARMACEUTICALS INC.

Original Applicant
03
Burnaby, B.C. CA

XENON PHARMACEUTICALS INC.

Owner at Publication
03
Burnaby, B.C. CA

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description Documents
Sep 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Sep 2, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 8, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jan 8, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 15, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 15, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 24, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 22, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 22, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 25, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 7, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 7, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 20, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 18, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 18, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 18, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 27, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 1, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 1, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 12, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 28, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 28, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 28, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 28, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 28, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 21, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 20, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological disorders
Class 044
Providing health information to patients and healthcare professionals relating to diagnosis and treatment of neurological disorders; providing information relating to patient access to diagnosis and treatment of neurological disorders via a website

Classification

International Classes
005 044